knowledge -WSS

knowledge

author：leisure time 2025-10-01 01:50:54 - browse：77

UnitedHealth's CEO Andrew Witty stares into the camera at a hearing with his fingers locked — politics coverage from STAT — Kent Nishimura/Getty Images

You’re reading the web version of Health Care Inc., STAT’s weekly newsletterfollowing the flow of money in medicine. Sign upto get it in your inbox every Monday.

About that 90,000 number

UnitedHealth Group CEO Andrew Witty faced Congress last week, where lawmakers pressed him on the Change Healthcare cyberattack (my colleague Brittany Trang watched the hearings closely and tried to break down what it all means). There was one particular exchange that’s worth highlighting.

To illustrate how large UnitedHealth has become, Sen. Elizabeth Warren (D-Mass.) cited how the company is the largest employer or “controller” of physicians, with 90,000 — roughly 10% of all U.S. physicians. Witty felt compelled to clarify that number.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Readout Newsletter: The latest at Gilead, Catalent, and the NIH

entertainment

WSS

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Readout LOUD podcast: A CRISPR milestone, biotech mixology

U.K. considers world's first use of meningitis vaccine to address gonorrhea

FDA's Woodcock to retire early next year

hotspot

knowledge

About that 90,000 number

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

In Memoriam: Notable people who died in 2023

Neuroscience startup Neumora files for IPO

Duchenne breakthrough therapy leaves behind pioneering families

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Walensky prepares to leave CDC — and Congress — behind

U.K. considers world's first use of meningitis vaccine to address gonorrhea

United colonoscopy coverage change 'may cost lives,' doctors say

Morphosys mixed study results for blood cancer drug

Hollywood unions extend contract negotiations for actors

Why medical students are struggling with mental health

leisure time

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Astellas still sees hope in its gene therapy after four deaths

Why more medical students aren't specializing in primary care

Study finds new variant for Parkinson’s in African populations

FDA panel gives mixed vote on blood pressure devices

David Sabatini, ex

leisure time

entertainment

hotspot

leisure time